Hims & Hers Health, Inc. (HIMS) spreader of May calls into quarter results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Hims & Hers earnings preview: BofA says company lost GLP-1 share in 1Q
May 11, 2026 12:00 PM EDTHims & Hers Health, Inc. (NYSE: HIMS) reports first-quarter results after the close on Monday, with Wall Street focused on the extent of market share losses, early signs of stabilization in April, and whether the company's nascent peptide opportunity can offset near-term headwinds in its core business.
Analyst consensus stands at $616.85 million in revenue and EPS... More
